Guangzhou Lanning Biotechnology Co., Ltd. is a service-oriented enterprise focusing on the research and development of impurity reference products involved in the process of drug registration, providing customized synthesis of impurity reference products, preparation and separation and the overall solution of impurity research in the process of drug registration. Professional research and development of drug impurity control products, own research and development laboratory, product quality control department, quality control. Complete spectrum, COA, hydrogen spectrum, carbon spectrum, mass spectrometry, liquid phase, ultraviolet, infrared. Spot can be delivered on the same day, order can provide samples, for the major pharmaceutical products through the consistency evaluation.
Penan is a new β-lactam antibacterial drug with the widest antibacterial spectrum and strong antibacterial activity
Cephalosporins are semi-synthetic antibiotics whose molecules contain cephalosporins and belong to the beta-lactam class of antibiotics
Belongs to the penicillin class beta lactam drugs, is the penicillin class of antibiotics
Antibiotic impurity reference material manufacturer
The 88th China International Pharmaceutical API/Intermediates/Packaging/Equipment Fair will be held in Qingdao, Shandong Province on April 12-14, 2023.
Qingdao Pharmaceutical Raw Materials Exhibition (API) is a professional platform dedicated to providing services for the whole industrial chain of pharmaceutical industry solutions. It is the flagship exhibition of new products and new technologies in China's pharmaceutical industry. The exhibition and the 26th CHINA International Pharmaceutical (Industry) Exhibition and Technology Exchange (China-PHARM) will work together to establish a foothold in the internal circulation of China's pharmaceutical industry, connect domestic and international pharmaceutical markets, share industry resources and market opportunities, and make joint efforts to realize the "mutual promotion of domestic and international double circulation" in the pharmaceutical industry. At the same time, it will promote the development of China's pharmaceutical economy to higher quality, stabilize the global industrial chain and supply chain, and build a new pharmaceutical landscape.
API China- focuses on improving the overall level of production and research and development of Chinese pharmaceutical apis, intermediates and pharmaceutical excipients. On behalf of new products and technologies of Chinese pharmaceutical industry, API China has become a brand event gathering industry leaders, displaying advanced product technology, interpreting policies and regulations for enterprises, improving the production level of the industry and reflecting the development trend of the industry. The exhibition was supported by more than 97% of China's top 100 pharmaceutical industry enterprises, providing opportunities for pharmaceutical decision-making, procurement, technology, research and development personnel to establish information exchange and business cooperation with target customers.
Coming soon
Scan it
